Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European stocks sharply lower amid Ukraine concerns; Dax down 0.84%

Published 04/25/2014, 03:49 AM
Updated 04/25/2014, 03:49 AM
European stocks drop on Ukraine tensions

Investing.com - European stocks were sharply lower on Friday, as concerns over fresh tensions between Ukraine and Russia dampened market sentiment, overshadowing comments by European Central Bank President Mario Draghi on Thursday.

During European morning trade, the DJ Euro Stoxx 50 slid 0.51%, France’s CAC 40 shed 0.34%, while Germany’s DAX retreated 0.84%.

Markets were jittery after Ukrainian forces killed up to five pro-Moscow rebels on Thursday. In response, Russia launched army drills near the border, sparking fears its troops would invade.

U.S. Secretary of State John Kerry said Washington was drawing closer to imposing more sanctions on Moscow.

European equities had strengthened on Thursday after ECB President Draghi said the bank could launch a "broad-based" asset purchase program if the medium-term inflation outlook worsened.

Financial stocks were broadly lower, as French lenders BNP Paribas (BNPP.PARIS) and Societe Generale (SOGN.PARIS) declined 0.41% and 1.31%, while Germany's Deutsche Bank (DBKGn.XETRA) tumbled 1.70%.

Deutsche Bank came under pressure following reports it is considering selling about €5 billion of shares to raise capital levels.

Among peripheral lenders, Italy's Intesa Sanpaolo (ISP.MILAN) and Unicredit (CRDI.MILAN) retreated 0.77% and 1.44% respectively, while Spanish banks Banco Santander (SAN.MADRID) and BBVA (BBVA.MADRID) slid 0.76% and 0.80%.

In earnings news, Philips Kon (PHG.AMS) reported first-quarter earnings that missed analysts’ estimates, sending shares in the Dutch phone company down 1.31%.

Tele2 (TEL2As.BS) also moved sharply lower, tumbling 1.28%, after releasing sales and profit figures that trailed market projections.

On the upside, Electrolux (ELUXa.ST) jumped 1.97% after posting earnings that exceeded estimates and increasing its forecast for European demand growth.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In London, FTSE 100 shed 0.34%, led by Astrazeneca (AZN.LONDON), down 2.26%, a day after the U.K.'s second biggest drugmaker reported first-quarter profit that missed analysts' estimates.

Financial stocks were also mostly lower, as Lloyds Banking (LLOY.LONDON) dropped 0.91% and Barclays (BARC.LONDON) lost 1.09%, while HSBC Holdings (HSBA.LONDON) plummeted 1.46%. The Royal Bank of Scotland (RBS.LONDON) overperformed however, adding 0.21%.

In the mining sector, stocks were broadly on the downside. Glencore Xstrata (GLEN.LONDON) and Bhp Billiton (BLT.LONDON) slipped 0.22% and 0.16% respectively, while rivals Polymetal (POLYP.LONDON) and Vedanta Resources (VED.LONDON) dropped 0.82% and 1.42%.

Meanwhile, Tate & Lyle (TATE.LONDON) led gains on the index, with shares surging 3.55%, boosted by reports the Bermuda-based food processing company Bunge could be on the verge of launching a £3.9billion for the food ingredients group.

In the U.S., equity markets pointed to a lower open. The Dow 30 futures pointed to a 0.24% fall, S&P 500 futures signaled a 0.15% slip, while the Nasdaq 100 futures indicated a 0.17% loss.

Later in the day, the U.S. was to release revised data on consumer sentiment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.